Skip to main content
Welcome to
super saver spring
offer ends april 20
save over $140
save over 85%
$0.99
per week for 24 weeks
Welcome to
super saver spring
$0.99
per week
for 24 weeks
// //

Isaac Bogoch is an infectious-diseases physician and scientist with the University of Toronto and Toronto General Hospital and a member of the COVID-19 Testing and Screening Expert Advisory Panel. Goldy Hyder is president and chief executive officer of the Business Council of Canada.

Canadians breathed a sigh of relief last month when Health Canada approved the first of what we all hope will be an increasing number of COVID-19 vaccines. But since then, reality has sunk in: The supply of vaccine doses available to Canada is limited, delivery delays are affecting rollout plans and while these early vaccines are extremely helpful to high-risk groups, widespread deployment will not occur until spring or beyond.

With each passing day, the pandemic exacts a heavier toll on lives, mental health, children’s education, employment and our general well-being.

Story continues below advertisement

As such, we can’t afford to rely on vaccines alone as the solution to the health emergency for the foreseeable future. We need other tools such as testing, including the widespread deployment of new, rapid, point-of-care tests. Doing so will allow more of us to get back to work and school safely and to begin rebuilding Canada’s economy.

Last fall, Health Canada began approving point-of-care tests, so called because they can be analyzed outside a laboratory, can diagnose COVID-19 within 15 minutes to an hour and are typically much cheaper than laboratory-based tests. The recent approval of a rapid test that uses a nasal swab that doesn’t need to go to the very back of your nose makes the use of these tests for screening even more appealing.

As of last November, the government of Canada had signed contracts to buy 38 million rapid point-of-care tests – roughly one for every Canadian. According to Prime Minister Justin Trudeau, 14 million rapid test kits have been delivered to provincial health authorities. That’s a start, but for a rapid-testing campaign to be useful we need the federal government to procure far more, and we need a commitment from each province to use them.

Rapid tests are not as accurate as conventional laboratory-based tests. Because of this, some public-health officials and health care professionals have been reluctant to roll them out in significant numbers.

However, we should not let perfection be the enemy of the good. Point-of-care tests are an important public-health tool to prevent the spread of COVID-19. The more we test, the more cases we are likely to find and the more we can limit the spread of the virus. In the real world, a reasonably accurate test that can be turned around quickly and administered frequently is often more useful than a more accurate test that must be sent to a lab for analysis, with results not available for days. That is why rapid tests are best suited to identify infected people with minimal or no symptoms, and to help ensure those individuals safely isolate before infecting others.

The federal government’s COVID-19 Testing and Screening Expert Advisory Panel recently released a report that gives jurisdictions strategies they can use to roll out point-of-care tests. For example, these tests can be used for screening people who may or may not have COVID-19 symptoms in workplaces where there is currently limited screening.

The NHL kept COVID-19 numbers down with frequent testing of its players. Similar screening strategies can be used in schools, or in small and medium-sized businesses to help them continue to operate during the pandemic and minimize the impact on Canada’s economy while vaccines roll out. Pilots from other countries are encouraging. For example, in regions of Slovakia where citizens participated in two rounds of testing over a two-week period, infection rates decreased by 60 per cent.

Story continues below advertisement

A recent report by Canada’s Industry Strategy Council calls for increased testing in Canada through collaboration between Canadian industry and the public-health system. Some of Canada’s biggest employers, including Bank of Nova Scotia and Loblaw, are getting on-board and setting up workplace COVID-19 rapid-testing pilot programs in collaboration with the University of Toronto’s Creative Destruction Lab. Employers in the construction, mining, fisheries and entertainment sectors have also begun screening employees for COVID-19.

Canadians are tired. They are tired of staying at home and being separated from friends and family, tired of lockdowns and job insecurity. Widespread rapid testing can help us get back to work and school safely and rebuild the economy while we wait our turn for the vaccine.

Keep your Opinions sharp and informed. Get the Opinion newsletter. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies